Physician profile
Bruce W Hallmann
NPI 1689770992
$4,441.65
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,428 · 2020: $14.07.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $3,193.09 | 2019 | |
| Medical Device Business Services, INC. | $571.16 | 2019 | |
| Smith+Nephew, INC. | $541.11 | 2019 | |
| Radius Health, INC. | $93.66 | 2019 | |
| Pacira Therapeutics, INC. | $22.43 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.07 | 2020 | |
| Depuy Synthes Sales INC. | $6.13 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$1,295,316.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Hallmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.